IF by specialty › Hematology
Blood Cancer Discovery — Impact Factor
The 2025 Impact Factor of Blood Cancer Discovery is 12.2 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 12.2 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- American Association for Cancer Research
- Open access
- subscription or hybrid
- IF source
- aacrjournals.org
Position within the field
Ranked 7 of the 38 journals in Hematology on this site (top 25%).
Hematology journals with a similar Impact Factor
- Blood Cancer Journal IF 13.8
- HemaSphere IF 11.3
- American Journal of Hematology IF 9.4
- Arteriosclerosis, Thrombosis, and Vascular Biology IF 8.8
- Leukemia IF 8.8
- Haematologica IF 8.2
About this value
The Journal Impact Factor of Blood Cancer Discovery (JCR 2025, released June 2026) is 12.2. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.